COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes
Authors:
- Zeinab Nabil Ahmed SaidZSZeinab Nabil Ahmed Said
- ESCMID Study Group for Viral HepatitisEHESCMID Study Group for Viral Hepatitis
Open Access
- 21 February 2023
- journal article
- editorial
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 29 (7) , 1123-1130
Abstract
COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomesKeywords
This publication has 64 references indexed in Scilit:
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV InfectionbioRxiv, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic AdaptationHepatology, 2019
- Liver Injury and Failure in Critical IllnessHepatology, 2019
- Hepatotoxicity by Drugs: The Most Common Implicated AgentsInternational Journal of Molecular Sciences, 2016
- Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitisHepatology, 2012
- Impact of hypoxic hepatitis on mortality in the intensive care unitIntensive Care Medicine, 2011
- Visceral fatHepatology, 2008
- SARS-associated viral hepatitis caused by a novel coronavirus: Report of three casesHepatology, 2004